Ivan Ilin

Mr. Ivan Ilin


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
ASAlexey V. Sulimov
Alexey V. Sulimov
DKDanil Kutov
Danil Kutov
EKEkaterina V. Katkova
Ekaterina V. Katkova
IIIvan Ilin
Ivan Ilin
VSVladimir Sulimov
Vladimir Sulimov

19 April 2020 in Molecules
Verified
Journal Article
Open access
PDF file
NNNadezhda Novichikhina
Nadezhda Novichikhina
IIIvan Ilin
Ivan Ilin
ATAnna Tashchilova
Anna Tashchilova
ASAlexey Sulimov
Alexey Sulimov
DKDanil Kutov
Danil Kutov
VSVladimir Sulimov
Vladimir Sulimov
Coagulation factor Xa and factor XIa are proven to be convenient and crucial protein targets for treatment for thrombotic disorders and thereby their inhibitors can serve as effective anticoagulant drugs. In the present work, we focused on the structure–activity relationships of derivatives of pyrrolo[3,2,1-ij]quinolin-2(1H)-one and an evaluation of their activity against factor Xa and factor XIa. For this, docking-guided synthesis of nine compounds based on pyrrolo[3,2,1-ij]quinolin-2(1H)-one was carried out. For the synthesis of new hybrid hydropyrrolo[3,2,1-ij]quinolin-2(1H)-one derivatives, we used convenient structural modification of both the tetrahydro- and dihydroquinoline moiety by varying the substituents at the C6,8,9 positions. In vitro testing revealed that four derivatives were able to inhibit both coagulation factors and three compounds were selective factor XIa inhibitors. An IC50 value of 3.68 μM for was found for the best factor Xa inhibitor and 2 μM for the best factor XIa inhibitor.

1 June 2019 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
IIIvan Ilin
Ivan Ilin
ELElena Lipets
Elena Lipets
ASAlexey Sulimov
Alexey Sulimov
DKDanil Kutov
Danil Kutov
KSKhidmet Shikhaliev
Khidmet Shikhaliev
VSVladimir Sulimov
Vladimir Sulimov

12 February 2022 in Molecules
Verified
Journal Article
Open access
PDF file
ATAnna Tashchilova
Anna Tashchilova
NPNadezhda Podoplelova
Nadezhda Podoplelova
ASAlexey Sulimov
Alexey Sulimov
DKDanil Kutov
Danil Kutov
IIIvan Ilin
Ivan Ilin
VSVladimir Sulimov
Vladimir Sulimov
In the modern world, complications caused by disorders in the blood coagulation system are found in almost all areas of medicine. Thus, the development of new, more advanced drugs that can prevent pathological conditions without disrupting normal hemostasis is an urgent task. The blood coagulation factor XIIa is one of the most promising therapeutic targets for the development of anticoagulants based on its inhibitors. The initial stage of drug development is directly related to computational methods of searching for a lead compound. In this study, docking followed by quantum chemical calculations was used to search for noncovalent low-molecular-weight factor XIIa inhibitors in a focused library of druglike compounds. As a result of the study, four low-molecular-weight compounds were experimentally confirmed as factor XIIa inhibitors. Selectivity testing revealed that two of the identified factor XIIa inhibitors were selective over the coagulation factors Xa and XIa.

5 September 2022 in Molecules
Verified
Journal Article
Open access
PDF file
ASAlexey Sulimov
Alexey Sulimov
IIIvan Ilin
Ivan Ilin
DKDanil Kutov
Danil Kutov
KSKhidmet Shikhaliev
Khidmet Shikhaliev
DSDmitry Shcherbakov
Dmitry Shcherbakov
VSVladimir Sulimov
Vladimir Sulimov
Candidates to being inhibitors of the main protease (Mpro) of SARS-CoV-2 were selected from the database of Voronezh State University using molecular modeling. The database contained approximately 19,000 compounds represented by more than 41,000 ligand conformers. These ligands were docked into Mpro using the SOL docking program. For one thousand ligands with best values of the SOL score, the protein–ligand binding enthalpy was calculated by the PM7 quantum-chemical method with the COSMO solvent model. Using the SOL score and the calculated protein–ligand binding enthalpies, eighteen compounds were selected for the experiments. Several of these inhibitors suppressed the replication of the coronavirus in cell culture, and we used the best three among them in the search for chemical analogs. Selection among analogs using the same procedure followed by experiments led to identification of seven inhibitors of the SARS-CoV-2 replication in cell culture with EC50 values at the micromolar level. The identified inhibitors belong to three chemical classes. The three inhibitors, 4,4-dimethyldithioquinoline derivatives, inhibit SARS-CoV-2 replication in Vero E6 cell culture just as effectively as the best published non-covalent inhibitors, and show low cytotoxicity. These results open up a possibility to develop antiviral drugs against the SARS-CoV-2 coronavirus.

24 September 2019 in SAR and QSAR in Environmental Research
Verified
Journal Article
Closed access
ASA. Sulimov
A. Sulimov
DKDanil Kutov
Danil Kutov
IIIvan Ilin
Ivan Ilin
DZD. Zheltkov
D. Zheltkov
ETE. Tyrtyshnikov
E. Tyrtyshnikov
VSVladimir Sulimov
Vladimir Sulimov
Docking represents one of the most popular computational approaches in drug design. It has reached popularity owing to capability of identifying correct conformations of a ligand within an active site of the target-protein and of estimating the binding affinity of a ligand that is immensely helpful in prediction of compound activity. Despite many success stories, there are challenges, in particular, handling with a large number of degrees of freedom in solving the docking problem. Here, we show that SOL-P, the docking program based on the new Tensor Train algorithm, is capable to dock successfully oligopeptides having up to 25 torsions. To make the study comparative we have performed docking of the same oligopeptides with the SOL program which uses the same force field as that utilized by SOL-P and has common features of many docking programs: the genetic algorithm of the global optimization and the grid approximation. SOL has managed to dock only one oligopeptide. Moreover, we present the results of docking with SOL-P ligands into proteins with moveable atoms. Relying on visual observations we have determined the common protein atom groups displaced after docking which seem to be crucial for successful prediction of experimental conformations of ligands.